Tate & Lyle PLC
SPLENDA(R) Sucralose to Be Used in Coca-Cola North America's New Addition to the
Diet Coke Family
Tate & Lyle PLC is pleased to confirm that, as Coca-Cola North America has
announced, SPLENDA(R) Sucralose will be used in the new addition to the Diet
Coke family to be launched in the second quarter of calendar 2005. Diet Coke
Sweetened with SPLENDA(R) Brand Sweetener will feature the SPLENDA(R) logo on
both the label and the packaging.
Whilst this was part of our business plan and will have no material impact on
Tate & Lyle's short term earnings, it is further confirmation of the longer term
market potential of SPLENDA(R) Sucralose.
About Tate & Lyle Tate & Lyle is a world leading manufacturer of renewable food
and industrial ingredients. It uses innovative technology to transform corn,
wheat and sugar into value-added ingredients for customers in the food,
beverage, pharmaceutical, cosmetic, paper, packaging and building industries.
The Company is a leader in cereal sweeteners and starches, sugar refining, value
added food and industrial ingredients, and citric acid. Tate & Lyle is the world
number-one in industrial starches and is the sole manufacturer of SPLENDA(R)
Sucralose.
Headquartered in London, Tate & Lyle is listed on the London Stock Exchange
under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company
operates more than 60 production facilities in 28 countries, throughout Europe,
the Americas and South East Asia. It employs 6,700 people in its subsidiaries
with a further 4,800 employed in joint ventures. Sales in the year to 31 March
2004 totalled £3.1 billion. Additional information can be found on
www.tateandlyle.com.
SPLENDA(R) is a trademark of McNeil Nutritionals, LLC
Contact: Tate & Lyle PLC:
Mark Robinson, Head of Investor Relations
Tel: +44(0)20 7626 6525 or Mobile: +44(0)7793 515 861
Email: investorrelations@tateandlyle.com
or
Ferne Hudson, Public Relations Manager (Press)
Tel: +44(0)20 7977 6143 or Mobile: +44(0)7713 067433
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.